Literature DB >> 15769919

A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica.

H A Bird1, B F Leeb, C M Montecucco, N Misiuniene, G Nesher, S Pai, C Pease, J Rovensky, B Rozman.   

Abstract

OBJECTIVE: To compare the performance of the several different diagnostic criteria sets currently in use for polymyalgia rheumatica (PMR).
METHODS: 213 patients attending eight rheumatological centres in eight different European countries were studied. All had recently been referred and were considered by the senior investigator at each centre, selected because of their experience in treatment of PMR, to have this condition. By use of a standard international proforma, the requisite diagnostic points in each criteria set were sought. Sensitivity for each criterion from each set was then calculated, as well as the sensitivity of each criteria set as a whole.
RESULTS: Of four criteria sets compared, the Bird (1979) criteria performed best with a sensitivity of 99.5%, and the Hunder (1982) criteria second best, with sensitivity of 93.3%. These both performed significantly better than the two other criteria sets, though each of these was admittedly developed for rather specialised reasons.
CONCLUSIONS: Although this study compares homogeneity, we suggest the Bird 1979 or Hunder 1982 criteria should be used whenever possible. Studies that have used alternative criteria may have less sensitivity in diagnosis.

Entities:  

Mesh:

Year:  2005        PMID: 15769919      PMCID: PMC1755435          DOI: 10.1136/ard.2004.025296

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  9 in total

1.  Proposed diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Ann Rheum Dis       Date:  1957-03       Impact factor: 19.103

2.  Myalgic syndrome with constitutional effects; polymyalgia rheumatica.

Authors:  H S BARBER
Journal:  Ann Rheum Dis       Date:  1957-06       Impact factor: 19.103

3.  Masked presentation of giant-cell arteritis.

Authors:  W S Wilke; A J Wysenbeek; P L Krall; A M Segal
Journal:  Cleve Clin Q       Date:  1985

4.  Polymyalgia rheumatica: a 10-year epidemiologic and clinical study.

Authors:  T Y Chuang; G G Hunder; D M Ilstrup; L T Kurland
Journal:  Ann Intern Med       Date:  1982-11       Impact factor: 25.391

5.  Prognosis and management of polymyalgia rheumatica.

Authors:  J G Jones; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1981-02       Impact factor: 19.103

Review 6.  Clinical studies of polymyalgia rheumatica. A proposal of diagnostic criteria.

Authors:  M Nobunaga; K Yoshioka; M Yasuda; M Shingu
Journal:  Jpn J Med       Date:  1989 Jul-Aug

7.  The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials.

Authors:  D T Felson; J J Anderson; M Boers; C Bombardier; M Chernoff; B Fried; D Furst; C Goldsmith; S Kieszak; R Lightfoot
Journal:  Arthritis Rheum       Date:  1993-06

8.  EULAR response criteria for polymyalgia rheumatica: results of an initiative of the European Collaborating Polymyalgia Rheumatica Group (subcommittee of ESCISIT).

Authors:  B F Leeb; H A Bird; G Nesher; I Andel; W Hueber; D Logar; C M Montecucco; J Rovensky; J Sautner; M Sonnenblick
Journal:  Ann Rheum Dis       Date:  2003-12       Impact factor: 19.103

9.  An evaluation of criteria for polymyalgia rheumatica.

Authors:  H A Bird; W Esselinckx; A S Dixon; A G Mowat; P H Wood
Journal:  Ann Rheum Dis       Date:  1979-10       Impact factor: 19.103

  9 in total
  17 in total

Review 1.  [Polymyalgia rheumatica: myalgic syndrome or occult vasculitis?].

Authors:  B Hellmich; W L Gross
Journal:  Internist (Berl)       Date:  2005-11       Impact factor: 0.743

Review 2.  Diagnosis, differential diagnosis and treatment of polymyalgia rheumatica.

Authors:  Thomas Nothnagl; Burkhard F Leeb
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

3.  Polymyalgia rheumatica and colon malignacy: case report.

Authors:  Tatjana Kehler; Bozidar Curković
Journal:  Clin Rheumatol       Date:  2005-10-25       Impact factor: 2.980

4.  Study of professional practices among rheumatologists in Burgundy: initial corticotherapy in polymyalgia rheumatica.

Authors:  Paul Ornetti; Caroline Guillibert-Karras; Jean-François Garrot; Florence Gros; Nathalie Gérard; Laurence Julien; Françoise Pascaud; Thierry Peere; Monique Petit-Perrin; Christine Piroth; Christian Tavernier; Jean-Francis Maillefert
Journal:  Clin Rheumatol       Date:  2010-11-18       Impact factor: 2.980

5.  The clinical course of polymyalgia rheumatica in Chinese.

Authors:  Wai Ling Li; Yi Lo; Moon Ho Leung; Woon Sing Wong; Mo Yin Mok
Journal:  Clin Rheumatol       Date:  2009-11-15       Impact factor: 2.980

Review 6.  Patient-reported outcomes in trials of patients with polymyalgia rheumatica: a systematic literature review.

Authors:  Annie Huang; Isabel Castrejon
Journal:  Rheumatol Int       Date:  2016-01-14       Impact factor: 2.631

7.  Clinical characteristics and prognostic factors for relapse in patients with polymyalgia rheumatica (PMR).

Authors:  Jung Hwa Lee; Sang Tae Choi; Jin Su Kim; Bo Young Yoon; Seung-Ki Kwok; Hyun-Sook Kim; Yun Sung Kim; Jung-Soo Song; Sang-Heon Lee; Hae-Rim Kim
Journal:  Rheumatol Int       Date:  2012-11-27       Impact factor: 2.631

8.  Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001.

Authors:  L Smeeth; C Cook; A J Hall
Journal:  Ann Rheum Dis       Date:  2006-01-13       Impact factor: 19.103

9.  Induction of remission is difficult due to frequent relapse during tapering steroids in Korean patients with polymyalgia rheumatica.

Authors:  Hyoun-Ah Kim; Jisoo Lee; You-Jung Ha; Sang-Hyon Kim; Chan-Hee Lee; Hyo-Jin Choi; Han-Joo Baek; Mie Jin Lim; Won Park; Sungiae Choi; Yeon-Sik Hong; Yoo-Hyun Lee; Bo-Ram Koh; Chang-Hee Suh
Journal:  J Korean Med Sci       Date:  2011-12-19       Impact factor: 2.153

10.  The rate of polymyalgia rheumatica (PMR) and remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome in a clinic where primary care physicians are working in Japan.

Authors:  Toshikatsu Okumura; Satoshi Tanno; Masumi Ohhira; Tsukasa Nozu
Journal:  Rheumatol Int       Date:  2011-03-24       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.